Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation
Sanam Ebtehaj, Eke G. Gruppen, Mojtaba Parvizi, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies
Raminderjit Kaur, Manpreet Kaur, Jatinder Singh
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 582
High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events
Congzhuo Jia, Josephine L.C. Anderson, Eke G. Gruppen, et al.
Circulation (2021) Vol. 143, Iss. 20, pp. 1935-1945
Open Access | Times Cited: 119
Steroid Transport, Local Synthesis, and Signaling within the Brain: Roles in Neurogenesis, Neuroprotection, and Sexual Behaviors
Nicolas Diotel, Thierry Charlier, Christian Lefebvre d’Hellencourt, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 147
Acute phase reactant serum amyloid A in inflammation and other diseases
Yan Zhang, Jie Zhang, Huiming Sheng, et al.
Advances in clinical chemistry (2019), pp. 25-80
Closed Access | Times Cited: 132
Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation
Yasaman Shokri, Atena Variji, Mani Nosrati, et al.
Diabetes Research and Clinical Practice (2020) Vol. 161, pp. 108067-108067
Closed Access | Times Cited: 74
HDL Functions—Current Status and Future Perspectives
Yasuhiro Endo, Masanori Fujita, Katsunori Ikewaki
Biomolecules (2023) Vol. 13, Iss. 1, pp. 105-105
Open Access | Times Cited: 39
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
Damien Denimal, Serge Monier, Benjamin Bouillet, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 253-253
Open Access | Times Cited: 26
Decoding the Link: Exploring FMO3 Gene Variations as a Key to Understanding Type Two Diabetes Through Bioinformatics and Case–Control Analyses
Shahrzad Shokati, Saman Sargazi, Mahdi Majidpour, et al.
Indian Journal of Clinical Biochemistry (2025)
Closed Access | Times Cited: 1
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?
Ke Liu, Mark E. Cooper, Zhonglin Chai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1683-1683
Open Access | Times Cited: 1
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes
Damien Denimal
Antioxidants (2023) Vol. 13, Iss. 1, pp. 57-57
Open Access | Times Cited: 20
ApoA-I and Diabetes
Thomas W. King, Blake J. Cochran, Kerry‐Anne Rye
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 8, pp. 1362-1368
Open Access | Times Cited: 17
High‐density lipoprotein in diabetes: Structural and functional relevance
David Tak Wai Lui, Kathryn Choon Beng Tan
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 7, pp. 805-816
Open Access | Times Cited: 6
Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease
Małgorzata Poręba, Paweł Rostoff, Aleksander Siniarski, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 52
HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity
Arianna Bonizzi, Gabriele Piuri, Fabio Corsi, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 729-729
Open Access | Times Cited: 35
Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study
Setor K. Kunutsor, Atanu Bhattacharjee, Margery A. Connelly, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2290-2290
Open Access | Times Cited: 5
Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study
Yinkun Yan, Shengxu Li, Liu Yang, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 42
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Sylwia Wasiak, Kim E. Dzobo, Brooke D. Rakai, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 36
High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
Andrea Bonnin Márquez, Sumra Nazir, Emiel P. C. van der Vorst
Biomedicines (2020) Vol. 8, Iss. 12, pp. 549-549
Open Access | Times Cited: 35
Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities
Damien Denimal, Sara Benanaya, Serge Monier, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. e3816-e3823
Open Access | Times Cited: 19
An Atherogenic Index of Plasma in Type 2 Diabetes Mellitus with and without Coronary Artery Disease
Nur Hasni Oktarina, Liong Boy Kurniawan, Nurahmi Nurahmi
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2025) Vol. 31, Iss. 2, pp. 185-190
Open Access
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants
David Rhainds, Jean‐Claude Tardif
Current Opinion in Lipidology (2019) Vol. 30, Iss. 2, pp. 101-107
Closed Access | Times Cited: 35
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
Carlo Cervellati, Giuseppe Valacchi, Veronica Tisato, et al.
Minerva Medica (2019) Vol. 110, Iss. 3
Open Access | Times Cited: 35
Monocyte-to-High-Density Lipoprotein Ratio Predicts the Outcome of Acute Ischemic Stroke
Hongbing Liu, Kai Liu, Lulu Pei, et al.
Journal of Atherosclerosis and Thrombosis (2020) Vol. 27, Iss. 9, pp. 959-968
Open Access | Times Cited: 32
Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL
Nicholas Hui, Philip J. Barter, Kwok Leung Ong, et al.
Clinical Science (2019) Vol. 133, Iss. 21, pp. 2221-2235
Closed Access | Times Cited: 30
Effect of advanced glycation end product on paraoxonase 2 expression: Its impact on endoplasmic reticulum stress and inflammation in HUVECs
Ramya Ravi, Nareshkumar Ragavachetty Nagaraj, Bharathidevi Subramaniam Rajesh
Life Sciences (2020) Vol. 246, pp. 117397-117397
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top